« BackRadiotherapy & Oncology
Article in Press

Predictive modelling for swallowing dysfunction after primary (chemo)radiation: Results of a prospective observational study

  • Miranda E.M.C. Christianen

      Affiliations

    • Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands
  • ,
  • Cornelis Schilstra

      Affiliations

    • Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands
  • ,
  • Ivo Beetz

      Affiliations

    • Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands
  • ,
  • Christina T. Muijs

      Affiliations

    • Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands
  • ,
  • Olga Chouvalova

      Affiliations

    • Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands
  • ,
  • Fred R. Burlage

      Affiliations

    • Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands
  • ,
  • Patricia Doornaert

      Affiliations

    • Department of Radiation Oncology, VU University Medical Center Amsterdam, The Netherlands
  • ,
  • Phil W. Koken

      Affiliations

    • Department of Radiation Oncology, VU University Medical Center Amsterdam, The Netherlands
  • ,
  • C. René Leemans

      Affiliations

    • Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center Amsterdam, The Netherlands
  • ,
  • Rico N.P.M. Rinkel

      Affiliations

    • Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center Amsterdam, The Netherlands
  • ,
  • Marieke J. de Bruijn

      Affiliations

    • Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center Amsterdam, The Netherlands
  • ,
  • G.H. de Bock

      Affiliations

    • Department of Epidemiology, University Medical Center Groningen, The Netherlands
  • ,
  • Jan L.N. Roodenburg

      Affiliations

    • Department of Oral and Maxillofacial Surgery, University Medical Center Groningen, The Netherlands
  • ,
  • Bernard F.A.M. van der Laan

      Affiliations

    • Department of Otolaryngology-Head and Neck Surgery, University Medical Center Groningen, University of Groningen, The Netherlands
  • ,
  • Ben J. Slotman

      Affiliations

    • Department of Radiation Oncology, VU University Medical Center Amsterdam, The Netherlands
  • ,
  • Irma M. Verdonck-de Leeuw

      Affiliations

    • Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center Amsterdam, The Netherlands
  • ,
  • Hendrik P. Bijl

      Affiliations

    • Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands
  • ,
  • Johannes A. Langendijk

      Affiliations

    • Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands
    • Corresponding Author InformationCorresponding author. Address: Department of Radiation Oncology, University Medical Center Groningen, P.O. Box 30001, 9300 RB Groningen, The Netherlands.

Received 26 April 2011; received in revised form 26 July 2011; accepted 9 August 2011. published online 12 September 2011.
Corrected Proof

Abstract 

Background and purpose

The purpose of this large multicentre prospective cohort study was to identify which dose volume histogram parameters and pre-treatment factors are most important to predict physician-rated and patient-rated radiation-induced swallowing dysfunction (RISD) in order to develop predictive models for RISD after curative (chemo) radiotherapy ((CH) RT).

Material and methods

The study population consisted of 354 consecutive head and neck cancer patients treated with (CH) RT. The primary endpoint was grade 2 or more swallowing dysfunction according to the RTOG/EORTC late radiation morbidity scoring criteria at 6months after (CH) RT. The secondary endpoints were patient-rated swallowing complaints as assessed with the EORTC QLQ-H&N35 questionnaire. To select the most predictive variables a multivariate logistic regression analysis with bootstrapping was used.

Results

At 6months after (CH) RT the bootstrapping procedure revealed that a model based on the mean dose to the superior pharyngeal constrictor muscle (PCM) and mean dose to the supraglottic larynx was most predictive.

For the secondary endpoints different predictive models were found: for problems with swallowing liquids the most predictive factors were the mean dose to the supraglottic larynx and radiation technique (3D-CRT versus IMRT). For problems with swallowing soft food the mean dose to the middle PCM, age (18–65 versus >65years), tumour site (naso/oropharynx versus other sites) and radiation technique (3D-CRT versus IMRT) were the most predictive factors. For problems with swallowing solid food the most predictive factors were the mean dose to the superior PCM, the mean dose to the supraglottic larynx and age (18–65 versus >65years). And for choking when swallowing the V60 of the oesophageal inlet muscle and the mean dose to the supraglottic larynx were the most predictive factors.

Conclusions

Physician-rated and patient-rated RISD in head and neck cancer patients treated with (CH) RT cannot be predicted with univariate relationships between the dose distribution in a single organ at risk and an endpoint. Separate predictive models are needed for different endpoints and factors other than dose volume histogram parameters are important as well.

Keywords: Radiotherapy, Swallowing dysfunction, Head and neck cancer, Normal tissue complication probability models, Nomograms

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0167-8140(11)00459-2

doi:10.1016/j.radonc.2011.08.009

« BackRadiotherapy & Oncology